申请人:Lu Shou-Fu
公开号:US20050020605A1
公开(公告)日:2005-01-27
The present invention relates to a series of compounds which are CCR-5 receptor antagonists of the general formula I:
or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein.
本发明涉及一系列通式I的CCR-5受体拮抗剂化合物,或其药学上可接受的盐,其中变量在此定义。